BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33615436)

  • 1. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
    Trottier AM; Godley LA
    Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
    Godley LA; DiNardo CD; Bolton K
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
    Schlegelberger B; Mecucci C; Wlodarski M
    Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
    Obiorah IE; Upadhyaya KD; Calvo KR
    Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Genetic Predisposition to Hematologic Malignancy.
    Furutani E; Shimamura A
    J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer predisposition syndromes associated with myeloid malignancy.
    Quinn E; Nichols KE
    Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
    Friend P; Mahon SM
    Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predisposition in acute leukaemia.
    Wiggins M; Stevenson W
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():75-81. PubMed ID: 32115888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
    Carraway HE; LaFramboise T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
    Mangaonkar AA; Patnaik MM
    Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline predisposition to hematopoietic malignancies.
    Feurstein S; Drazer M; Godley LA
    Hum Mol Genet; 2021 Oct; 30(20):R225-R235. PubMed ID: 34100074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical considerations for diagnosis and management of patients and carriers.
    Niemeyer CM; Mecucci C
    Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological Malignancies in Adults With a Family Predisposition.
    Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
    Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.